Allylamine cardiotoxicity-IV. Metabolism to acrolein by cardiovascular tissues

Thomas J. Nelson, Paul J. Boor

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Acrolein was detected in homogenates of rat aorta, lung, skeletal muscle, and heart incubated with allylamine. Semicarbazide and hydralazine, which protect against allylamine-induced myocardial injury in vivo in the rat, inhibited acrolein formation. Hydrogen peroxide, a product of oxidative deamination, was generated during allylamine oxidation. Acrolein was also produced from allylamine by bovine plasma amine oxidase and porcine kidney diamine oxidase but not by rat liver or brain homogenates. Allylamine competitively inhibited benzylamine oxidation in rat aorta, but pargyline- sensitive monoamine oxidase was not involved in acrolein production. The high activity in aorta, the competition with benzylamine, and the sensitivity to benzylamine oxidase inhibitors indicate that benzylamine oxidase is the active enzyme in oxidizing allylamine. The formation of acrolein may be the basis of the cardiotoxic action of allylamine.

Original languageEnglish (US)
Pages (from-to)509-514
Number of pages6
JournalBiochemical Pharmacology
Volume31
Issue number4
DOIs
StatePublished - Feb 15 1982

Fingerprint

Allylamine
Acrolein
Metabolism
Tissue
Rats
Benzylamine Oxidase
Aorta
Pargyline
Amine Oxidase (Copper-Containing)
Hydralazine
Oxidation
Deamination
Monoamine Oxidase
Cardiotoxicity
Liver
Hydrogen Peroxide
Amines
Muscle
Brain
Oxidoreductases

ASJC Scopus subject areas

  • Pharmacology

Cite this

Allylamine cardiotoxicity-IV. Metabolism to acrolein by cardiovascular tissues. / Nelson, Thomas J.; Boor, Paul J.

In: Biochemical Pharmacology, Vol. 31, No. 4, 15.02.1982, p. 509-514.

Research output: Contribution to journalArticle

Nelson, Thomas J. ; Boor, Paul J. / Allylamine cardiotoxicity-IV. Metabolism to acrolein by cardiovascular tissues. In: Biochemical Pharmacology. 1982 ; Vol. 31, No. 4. pp. 509-514.
@article{1a04d739db2a43e9a7438cc37f7bd76e,
title = "Allylamine cardiotoxicity-IV. Metabolism to acrolein by cardiovascular tissues",
abstract = "Acrolein was detected in homogenates of rat aorta, lung, skeletal muscle, and heart incubated with allylamine. Semicarbazide and hydralazine, which protect against allylamine-induced myocardial injury in vivo in the rat, inhibited acrolein formation. Hydrogen peroxide, a product of oxidative deamination, was generated during allylamine oxidation. Acrolein was also produced from allylamine by bovine plasma amine oxidase and porcine kidney diamine oxidase but not by rat liver or brain homogenates. Allylamine competitively inhibited benzylamine oxidation in rat aorta, but pargyline- sensitive monoamine oxidase was not involved in acrolein production. The high activity in aorta, the competition with benzylamine, and the sensitivity to benzylamine oxidase inhibitors indicate that benzylamine oxidase is the active enzyme in oxidizing allylamine. The formation of acrolein may be the basis of the cardiotoxic action of allylamine.",
author = "Nelson, {Thomas J.} and Boor, {Paul J.}",
year = "1982",
month = "2",
day = "15",
doi = "10.1016/0006-2952(82)90152-6",
language = "English (US)",
volume = "31",
pages = "509--514",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Allylamine cardiotoxicity-IV. Metabolism to acrolein by cardiovascular tissues

AU - Nelson, Thomas J.

AU - Boor, Paul J.

PY - 1982/2/15

Y1 - 1982/2/15

N2 - Acrolein was detected in homogenates of rat aorta, lung, skeletal muscle, and heart incubated with allylamine. Semicarbazide and hydralazine, which protect against allylamine-induced myocardial injury in vivo in the rat, inhibited acrolein formation. Hydrogen peroxide, a product of oxidative deamination, was generated during allylamine oxidation. Acrolein was also produced from allylamine by bovine plasma amine oxidase and porcine kidney diamine oxidase but not by rat liver or brain homogenates. Allylamine competitively inhibited benzylamine oxidation in rat aorta, but pargyline- sensitive monoamine oxidase was not involved in acrolein production. The high activity in aorta, the competition with benzylamine, and the sensitivity to benzylamine oxidase inhibitors indicate that benzylamine oxidase is the active enzyme in oxidizing allylamine. The formation of acrolein may be the basis of the cardiotoxic action of allylamine.

AB - Acrolein was detected in homogenates of rat aorta, lung, skeletal muscle, and heart incubated with allylamine. Semicarbazide and hydralazine, which protect against allylamine-induced myocardial injury in vivo in the rat, inhibited acrolein formation. Hydrogen peroxide, a product of oxidative deamination, was generated during allylamine oxidation. Acrolein was also produced from allylamine by bovine plasma amine oxidase and porcine kidney diamine oxidase but not by rat liver or brain homogenates. Allylamine competitively inhibited benzylamine oxidation in rat aorta, but pargyline- sensitive monoamine oxidase was not involved in acrolein production. The high activity in aorta, the competition with benzylamine, and the sensitivity to benzylamine oxidase inhibitors indicate that benzylamine oxidase is the active enzyme in oxidizing allylamine. The formation of acrolein may be the basis of the cardiotoxic action of allylamine.

UR - http://www.scopus.com/inward/record.url?scp=0020036935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020036935&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(82)90152-6

DO - 10.1016/0006-2952(82)90152-6

M3 - Article

VL - 31

SP - 509

EP - 514

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 4

ER -